{
    "hands_on_practices": [
        {
            "introduction": "The Body Mass Index, or BMI, is a cornerstone of obesity screening in both clinical and public health settings. While its formula, $BMI = \\frac{w}{h^2}$, is simple, its practical application is sensitive to measurement precision. This exercise  demonstrates how a seemingly minor error in height measurement can propagate into a significant miscalculation of $BMI$, potentially affecting clinical decisions. Mastering this analysis will underscore the critical importance of meticulous data collection in preventive medicine.",
            "id": "4557424",
            "problem": "In preventive medicine, accurate screening for excess adiposity relies on the Body Mass Index (BMI), defined as $BMI = \\dfrac{w}{h^{2}}$, where $w$ is body mass in $\\mathrm{kg}$ and $h$ is height in $\\mathrm{m}$. Consider an adult whose mass is measured without error as $w = 80\\,\\mathrm{kg}$. A stadiometer underestimates this personâ€™s height by $0.01\\,\\mathrm{m}$, so the recorded height is $h_{m} = 1.70\\,\\mathrm{m}$, while the true height is $h_{t} = 1.71\\,\\mathrm{m}$. Starting only from the BMI definition and the definition of relative error, first derive symbolically the multiplicative bias in BMI induced by an underestimated height, and then evaluate the relative error in BMI for the given numbers. Report the relative error in BMI, defined as $\\dfrac{BMI_{\\text{measured}} - BMI_{\\text{true}}}{BMI_{\\text{true}}}$, as a decimal (no percent sign), rounded to four significant figures. Do not include units in your final answer.",
            "solution": "The problem as stated is scientifically grounded, well-posed, and objective. It is based on the standard definition of Body Mass Index (BMI) and the fundamental principles of error analysis. All necessary data are provided, and they are internally consistent and physically realistic. Therefore, the problem is valid and a solution will be provided.\n\nThe Body Mass Index (BMI) is defined as:\n$$\nBMI = \\frac{w}{h^2}\n$$\nwhere $w$ is the body mass in kilograms ($\\mathrm{kg}$) and $h$ is the height in meters ($\\mathrm{m}$).\n\nLet $w$ be the true mass, $h_t$ be the true height, and $h_m$ be the measured height. The problem states that the mass is measured without error, so the same value $w$ is used for both calculations. The true BMI, $BMI_t$, and the measured BMI, $BMI_m$, are given by:\n$$\nBMI_t = \\frac{w}{h_t^2}\n$$\n$$\nBMI_m = \\frac{w}{h_m^2}\n$$\n\nThe first task is to derive symbolically the multiplicative bias in BMI. The multiplicative bias, which we can denote as $k$, is the factor by which the true BMI is multiplied to obtain the measured BMI. It is the ratio of the measured BMI to the true BMI.\n$$\nk = \\frac{BMI_m}{BMI_t}\n$$\nSubstituting the expressions for $BMI_m$ and $BMI_t$:\n$$\nk = \\frac{\\left(\\frac{w}{h_m^2}\\right)}{\\left(\\frac{w}{h_t^2}\\right)}\n$$\nThe mass $w$ cancels out, yielding the symbolic expression for the multiplicative bias:\n$$\nk = \\frac{h_t^2}{h_m^2} = \\left(\\frac{h_t}{h_m}\\right)^2\n$$\nSince the height is underestimated, we have $h_m < h_t$, which implies that the ratio $\\frac{h_t}{h_m} > 1$. Consequently, the bias factor $k > 1$, indicating that an underestimation of height leads to an overestimation of BMI.\n\nThe second task is to evaluate the relative error in BMI for the given numbers. The relative error, which we will denote as $\\epsilon_{BMI}$, is defined in the problem statement as:\n$$\n\\epsilon_{BMI} = \\frac{BMI_m - BMI_t}{BMI_t}\n$$\nThis expression can be simplified by separating the fraction:\n$$\n\\epsilon_{BMI} = \\frac{BMI_m}{BMI_t} - \\frac{BMI_t}{BMI_t} = \\frac{BMI_m}{BMI_t} - 1\n$$\nWe have already derived the ratio $\\frac{BMI_m}{BMI_t}$, which is the multiplicative bias $k$. Thus, the relative error can be expressed symbolically as:\n$$\n\\epsilon_{BMI} = \\left(\\frac{h_t}{h_m}\\right)^2 - 1\n$$\nThe problem provides the following numerical values:\n- True height, $h_t = 1.71\\,\\mathrm{m}$\n- Measured height, $h_m = 1.70\\,\\mathrm{m}$\n- Body mass (not needed for this calculation), $w = 80\\,\\mathrm{kg}$\n\nSubstituting the values for height into the expression for the relative error:\n$$\n\\epsilon_{BMI} = \\left(\\frac{1.71}{1.70}\\right)^2 - 1\n$$\nTo perform the calculation exactly, we can treat the numbers as fractions:\n$$\n\\epsilon_{BMI} = \\left(\\frac{171/100}{170/100}\\right)^2 - 1 = \\left(\\frac{171}{170}\\right)^2 - 1\n$$\n$$\n\\epsilon_{BMI} = \\frac{171^2}{170^2} - 1 = \\frac{171^2 - 170^2}{170^2}\n$$\nUsing the algebraic identity for the difference of squares, $a^2 - b^2 = (a-b)(a+b)$:\n$$\n171^2 - 170^2 = (171 - 170)(171 + 170) = (1)(341) = 341\n$$\nAnd the denominator is:\n$$\n170^2 = 28900\n$$\nSo, the exact relative error is:\n$$\n\\epsilon_{BMI} = \\frac{341}{28900}\n$$\nNow, we convert this fraction to a decimal:\n$$\n\\epsilon_{BMI} \\approx 0.01180069204...\n$$\nThe problem requires the answer to be rounded to four significant figures. The first non-zero digit is $1$ (in the hundredths place), so the first four significant figures are $1$, $1$, $8$, and $0$. The fifth significant figure is $0$, so we round down (i.e., we truncate at the fourth significant figure).\n$$\n\\epsilon_{BMI} \\approx 0.01180\n$$",
            "answer": "$$\\boxed{0.01180}$$"
        },
        {
            "introduction": "After identifying a patient's risk using metrics like $BMI$, the next step is often to consider management strategies. Evaluating the real-world effectiveness of these strategies is a core skill in evidence-based medicine. This exercise  challenges you to step into the role of a clinical epidemiologist, using data analogous to that from major pharmacotherapy trials to calculate the Number Needed to Treat ($NNT$). This powerful metric translates trial results into a tangible number that informs both clinical decision-making and patient counseling.",
            "id": "4557471",
            "problem": "A randomized patient with obesity has baseline body weight $W_{0} = 100$ kilograms. Consider one-year outcomes from a large, well-controlled trial comparing semaglutide $2.4$ milligrams to placebo, where the observed mean percentage weight loss at $1$ year was $14.9$ for semaglutide and $2.4$ for placebo, and the observed proportions of participants achieving at least $10$ percentage weight loss were $0.69$ under semaglutide and $0.12$ under placebo. Starting from core definitions in preventive medicine and biostatistics, use the following foundations:\n\n- The expected value (mean) of a treatment effect is the population mean of the observed outcome under that treatment.\n- Percentage change is defined as the absolute change divided by the baseline, and an absolute change in weight equals the baseline weight multiplied by the fractional percentage change.\n- Absolute risk is the probability of an event; absolute risk reduction is the difference in these probabilities between treatment and control; and Number Needed to Treat (NNT) is the reciprocal of the absolute risk reduction.\n\nDerive the expected average absolute weight loss at one year for semaglutide versus placebo, expressed as the between-group difference in kilograms. Then compute the NNT to achieve at least $10$ percentage weight loss. Round both quantities to three significant figures. Express the weight difference in kilograms and the NNT as a number of patients. Provide your final answer as a two-entry row matrix, with the first entry being the kilogram difference and the second entry being the NNT.",
            "solution": "The problem statement has been validated and is deemed valid. It is scientifically grounded in established principles of biostatistics and preventive medicine, is well-posed with sufficient and consistent information, and is expressed in objective, formalizable language.\n\nThe problem requires the calculation of two quantities: the expected average absolute weight loss difference between semaglutide and placebo, and the Number Needed to Treat (NNT) to achieve a specific weight loss threshold.\n\nLet $W_0$ be the baseline body weight, given as $W_0 = 100$ kilograms.\n\nFirst, we calculate the expected average absolute weight loss difference.\nThe mean percentage weight loss for the semaglutide group is given as $14.9\\%$. Let this be $\\Delta W_{\\%, S}$. As a fraction, this is $\\Delta W_{\\text{frac}, S} = 0.149$.\nThe mean percentage weight loss for the placebo group is given as $2.4\\%$. Let this be $\\Delta W_{\\%, P}$. As a fraction, this is $\\Delta W_{\\text{frac}, P} = 0.024$.\n\nAccording to the problem's definition, the absolute change in weight is the product of the baseline weight and the fractional percentage change.\nThe expected absolute weight loss for the semaglutide group, $\\Delta W_S$, is:\n$$ \\Delta W_S = W_0 \\times \\Delta W_{\\text{frac}, S} $$\n$$ \\Delta W_S = 100 \\text{ kg} \\times 0.149 = 14.9 \\text{ kg} $$\n\nThe expected absolute weight loss for the placebo group, $\\Delta W_P$, is:\n$$ \\Delta W_P = W_0 \\times \\Delta W_{\\text{frac}, P} $$\n$$ \\Delta W_P = 100 \\text{ kg} \\times 0.024 = 2.4 \\text{ kg} $$\n\nThe between-group difference in expected average absolute weight loss, denoted $\\Delta(\\Delta W)$, is the difference between these two values:\n$$ \\Delta(\\Delta W) = \\Delta W_S - \\Delta W_P $$\n$$ \\Delta(\\Delta W) = 14.9 \\text{ kg} - 2.4 \\text{ kg} = 12.5 \\text{ kg} $$\nThis value is already expressed to three significant figures.\n\nSecond, we compute the Number Needed to Treat (NNT). The clinical endpoint, or event of interest, is achieving at least $10\\%$ percentage weight loss.\nThe problem provides the observed proportions of participants who achieved this endpoint. These proportions are the empirical estimates of a patient's probability of achieving the outcome in each group, which corresponds to the definition of absolute risk (AR).\n\nLet $AR_S$ be the absolute risk of the event in the semaglutide group. This is given as $AR_S = 0.69$.\nLet $AR_P$ be the absolute risk of the event in the placebo (control) group. This is given as $AR_P = 0.12$.\n\nThe Absolute Risk Reduction (ARR) is defined as the difference in absolute risks between the treatment and control groups:\n$$ \\text{ARR} = AR_S - AR_P $$\n$$ \\text{ARR} = 0.69 - 0.12 = 0.57 $$\n\nThe Number Needed to Treat (NNT) is defined as the reciprocal of the Absolute Risk Reduction:\n$$ \\text{NNT} = \\frac{1}{\\text{ARR}} $$\n$$ \\text{NNT} = \\frac{1}{0.57} \\approx 1.75438596... $$\nThe problem requires this value to be rounded to three significant figures.\n$$ \\text{NNT} \\approx 1.75 $$\n\nThe final answer is a two-entry row matrix containing the kilogram difference and the NNT. The first entry is $12.5$ and the second is $1.75$.",
            "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n12.5 & 1.75\n\\end{pmatrix}\n}\n$$"
        },
        {
            "introduction": "To design effective public health policies, we must move beyond individual risk and quantify the burden of disease at a population level. This allows us to understand the potential impact of large-scale prevention efforts. This problem  guides you through the derivation and calculation of the Population Attributable Fraction ($PAF$). By working through this example, you will learn how to estimate the proportion of a common comorbidity, Type 2 Diabetes Mellitus, that could be prevented if obesity were eliminated from the population, a crucial insight for prioritizing health interventions.",
            "id": "4557475",
            "problem": "A public health team in a metropolitan region is evaluating the preventable burden of Type 2 Diabetes Mellitus (T2DM) due to obesity. In the adult population, the prevalence of obesity is $P_{e} = 0.35$. A recent longitudinal cohort study, with appropriate control for confounding, estimates the Relative Risk (RR) of incident T2DM for individuals with obesity compared to those without obesity as $RR = 3.0$. Assume that the association is causal and that eliminating obesity would set the incidence among those previously exposed equal to the incidence among the unexposed, with all other factors remaining constant.\n\nStarting from fundamental definitions, derive the Population Attributable Fraction (PAF), defined as the proportion of current disease incidence in the population that would be prevented if the exposure were eliminated, in terms of the exposure prevalence $P_{e}$ and the relative risk $RR$. Then, compute the numerical value of the PAF for the given parameters. Provide an exact value; do not round. Express the final answer as a dimensionless fraction. Finally, briefly interpret the result in terms of the burden of T2DM attributable to obesity under the stated assumptions.",
            "solution": "The problem is valid. It is a well-posed question in epidemiology that is scientifically grounded, objective, and contains sufficient information for a unique solution. The provided parameters are realistic for the association between obesity and Type 2 Diabetes Mellitus (T2DM).\n\nWe begin by deriving the formula for the Population Attributable Fraction (PAF) from fundamental definitions.\n\nLet $I_t$ be the total incidence rate of T2DM in the population.\nLet $I_e$ be the incidence rate of T2DM in the exposed group (individuals with obesity).\nLet $I_u$ be the incidence rate of T2DM in the unexposed group (individuals without obesity).\nLet $P_e$ be the prevalence of the exposure (obesity) in the population. Then, the prevalence of the unexposed is $P_u = 1 - P_e$.\n\nThe total incidence in the population, $I_t$, can be expressed as the weighted average of the incidence rates in the exposed and unexposed subgroups, where the weights are the prevalences of these subgroups:\n$$I_t = (I_e \\times P_e) + (I_u \\times P_u)$$\nSubstituting $P_u = 1 - P_e$, we get:\n$$I_t = (I_e \\times P_e) + (I_u \\times (1 - P_e))$$\n\nThe Relative Risk, $RR$, is defined as the ratio of the incidence in the exposed group to the incidence in the unexposed group:\n$$RR = \\frac{I_e}{I_u}$$\nFrom this definition, we can express the incidence in the exposed group in terms of the incidence in the unexposed group and the relative risk:\n$$I_e = RR \\times I_u$$\n\nNow, we substitute this expression for $I_e$ into the equation for the total incidence $I_t$:\n$$I_t = ((RR \\times I_u) \\times P_e) + (I_u \\times (1 - P_e))$$\nFactoring out $I_u$, we obtain:\n$$I_t = I_u (RR \\times P_e + 1 - P_e)$$\n\nThe Population Attributable Fraction (PAF) is defined as the proportion of the disease incidence in the total population that is attributable to the exposure. This is the proportion of incidence that would be prevented if the exposure were eliminated. If the exposure (obesity) were eliminated, under the given causal and counterfactual assumptions, the incidence rate for the entire population would become equal to the incidence rate of the unexposed group, $I_u$.\n\nThe absolute reduction in incidence in the population would be the difference between the current total incidence and the hypothetical incidence without the exposure:\n$$ \\text{Incidence Reduction} = I_t - I_u $$\nThe PAF is this reduction expressed as a fraction of the current total incidence:\n$$ \\text{PAF} = \\frac{I_t - I_u}{I_t} = 1 - \\frac{I_u}{I_t} $$\n\nTo obtain the final formula in terms of $P_e$ and $RR$, we substitute our expression for $I_t$:\n$$ \\text{PAF} = 1 - \\frac{I_u}{I_u (RR \\times P_e + 1 - P_e)} $$\nThe term $I_u$ cancels out from the numerator and denominator:\n$$ \\text{PAF} = 1 - \\frac{1}{RR \\times P_e + 1 - P_e} $$\nTo combine this into a single fraction, we find a common denominator:\n$$ \\text{PAF} = \\frac{(RR \\times P_e + 1 - P_e) - 1}{RR \\times P_e + 1 - P_e} $$\n$$ \\text{PAF} = \\frac{RR \\times P_e - P_e}{RR \\times P_e + 1 - P_e} $$\nFactoring out $P_e$ from the numerator gives the commonly used formula for PAF:\n$$ \\text{PAF} = \\frac{P_e (RR - 1)}{P_e (RR - 1) + 1} $$\nThis completes the derivation of the PAF formula.\n\nNext, we compute the numerical value of the PAF using the given parameters: $P_e = 0.35$ and $RR = 3.0$.\nSubstituting these values into the derived formula:\n$$ \\text{PAF} = \\frac{0.35 (3.0 - 1)}{0.35 (3.0 - 1) + 1} $$\n$$ \\text{PAF} = \\frac{0.35 \\times 2.0}{0.35 \\times 2.0 + 1} $$\n$$ \\text{PAF} = \\frac{0.7}{0.7 + 1} $$\n$$ \\text{PAF} = \\frac{0.7}{1.7} $$\nTo express this as an exact dimensionless fraction, we can write the decimals as fractions of $10$:\n$$ \\text{PAF} = \\frac{7/10}{17/10} = \\frac{7}{17} $$\n\nFinally, we interpret the result. A PAF of $7/17$ (approximately $0.4118$ or $41.18\\%$) means that, under the assumption that the observed association between obesity and T2DM is causal, $41.18\\%$ of all new cases of T2DM in this adult population are attributable to obesity. Phrased differently, if obesity were completely eliminated from this population and all other factors remained unchanged, the public health team could expect the incidence of T2DM to decrease by approximately $41.18\\%$. This value quantifies the substantial burden of T2DM that is preventable through the elimination of obesity in this specific population.",
            "answer": "$$\n\\boxed{\\frac{7}{17}}\n$$"
        }
    ]
}